Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipid syndrome (APS) directly bind to beta(2)-glycoprotein I (beta(2)-GPI), which is adsorbed to an oxidized polystyrene surface. Oxygen atoms were introduced on a polystyrene surface by irradiation with electron or gamma-ray radiation. X-ray photoelectron spectroscopy revealed the irradiated surfaces were oxidized to generate C-O and C=O moieties. aCL derived from either APS patients or (NZW x BXSB)F-1 mice bound to beta(2)-GPI coated on the irradiated plates, depending on the radiation dose. Antibody binding to beta(2)-GPI on the irradiated plates was competitively inhibited by simultaneous addition of cardiolipin (CL)-coated latex beads mixed ...
Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic an...
Beta-2-GPI is a 50 kDa glycoprotein which is known to be a serum co-factor, with a role in determini...
We read with great interest the thorough review by Roubey ’ on the antiphospholipid syndrome. Howeve...
Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipi...
Anti-cardiolipin autoantibodies (aCL) induce thrombosis and recurrent fetal death. These antibodies ...
Circulating autoantibodies to phospholipids (aPLs), such as cardiolipin (CL), are found in patients ...
Anticardiolipin (aCL) and anti-beta(2)-glycoprotein I(anti beta 2GPI) antibodies have been shown in ...
BackgroundWe recently suggested that many anticardiolipin antibodies bind only to oxidized cardiolip...
The antiphospholipid antibodies (aPL) present in autoimmune disorders are associated with thromboemb...
The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncerta...
The antiphospholipid syndrome is defined by the presence of antiphospholipid antibodies in blood of ...
This study has been undertaken to assess whether anticardiolipin and anti-beta 2-GPI are two distinc...
The online version of this article, along with updated information and services, is located on th
dangeac@univ-montp2.frInternational audienceBinding of beta 2GPI (beta2 glycoprotein I), a human pla...
Since the aCL test was first described, several reports have described the heterogeneity of aPL, whi...
Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic an...
Beta-2-GPI is a 50 kDa glycoprotein which is known to be a serum co-factor, with a role in determini...
We read with great interest the thorough review by Roubey ’ on the antiphospholipid syndrome. Howeve...
Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipi...
Anti-cardiolipin autoantibodies (aCL) induce thrombosis and recurrent fetal death. These antibodies ...
Circulating autoantibodies to phospholipids (aPLs), such as cardiolipin (CL), are found in patients ...
Anticardiolipin (aCL) and anti-beta(2)-glycoprotein I(anti beta 2GPI) antibodies have been shown in ...
BackgroundWe recently suggested that many anticardiolipin antibodies bind only to oxidized cardiolip...
The antiphospholipid antibodies (aPL) present in autoimmune disorders are associated with thromboemb...
The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncerta...
The antiphospholipid syndrome is defined by the presence of antiphospholipid antibodies in blood of ...
This study has been undertaken to assess whether anticardiolipin and anti-beta 2-GPI are two distinc...
The online version of this article, along with updated information and services, is located on th
dangeac@univ-montp2.frInternational audienceBinding of beta 2GPI (beta2 glycoprotein I), a human pla...
Since the aCL test was first described, several reports have described the heterogeneity of aPL, whi...
Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic an...
Beta-2-GPI is a 50 kDa glycoprotein which is known to be a serum co-factor, with a role in determini...
We read with great interest the thorough review by Roubey ’ on the antiphospholipid syndrome. Howeve...